6-K//Foreign company update
Transition Therapeutics Inc. 6-K
Accession 0001144204-16-100873
CIK 0001399250other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:35 PM ET
Size
699.9 KB
Accession
0001144204-16-100873
Documents
- 6-Kv439356_6k.htmPrimary
6-K
- EX-99.1v439356_ex99-1.htm
PRESS RELEASE DATED MAY 11, 2016
- EX-99.2v439356_ex99-2.htm
MANAGEMENTS DISCUSSION AND ANALYSIS
- EX-99.3v439356_ex99-3.htm
CONSOLIDATED FINANCIAL STATEMENTS
- EX-99.4v439356_ex99-4.htm
CERTIFICATION OF INTERIM FILINGS SIGNED BY THE CHIEF EXECUTIVE OFFICER
- EX-99.5v439356_ex99-5.htm
CERTIFICATION OF INTERIM FILINGS SIGNED BY THE CHIEF FINANCIAL OFFICER
- EX-99.6v439356_ex99-6.htm
LETTER TO SHAREHOLDERS
- GRAPHICtex99-1_logo.jpg
GRAPHIC
- GRAPHICtex99-2_chart.jpg
GRAPHIC
- GRAPHICtsig1.jpg
GRAPHIC
- GRAPHICtsig2.jpg
GRAPHIC
Issuer
Transition Therapeutics Inc.
CIK 0001399250
Entity typeother
Related Parties
1- filerCIK 0001399250
Filing Metadata
- Form type
- 6-K
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:35 PM ET
- Size
- 699.9 KB